Question · asked by 1 review
Hydroxyurea vs RBC transfusion: Quality of life ‐ not reported
- Population
- prevention of SCI in people with SCD who had a stroke (secondary prevention)
- Intervention
- Hydroxyurea
- Comparison
- RBC transfusion
- Outcome
- Quality of life ‐ not reported
The review found no eligible studies for this question.
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Hydroxyurea vs RBC transfusion Quality of life ‐ not reported · prevention of SCI in people with SCD who had a stroke (secondary prevention) The review found no eligible studies for this question. Interventions for preventing silent cerebral infarcts in people with sickle cell disease (2020) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Interventions for preventing silent cerebral infarcts in people with sickle cell disease 2020 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Hydroxyurea vs RBC transfusion · prevention of SCI in people with SCD who have not had a stroke (primary prevention) · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.